Report cover image

Teijin Ltd (3401) - Financial and Strategic SWOT Analysis Review

Publisher GlobalData
Published Dec 31, 2025
Length 65 Pages
SKU # GBDT20700113

Description

Teijin Ltd (3401) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Teijin Ltd (Teijin) is a technology-driven holding company that offers solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. The company manufactures and sells aramid fiber, carbon fiber products, synthetic fiber, films, polyester films, resin products, chemical products, IT products and pharmaceutical products. Teijin offers pharmaceuticals for treating bone and joint diseases, respiratory diseases, cardiovascular and metabolic diseases, and other diseases. It also offers homecare services such as home oxygen therapy devices, sonic accelerated fracture healing systems, and sleep-disordered breathing-related devices, among others. The company operates facilities in Europe, America, Asia and Japan. It sells its products in Asia, the Americas, and Europe. Teijin is headquartered in Tokyo, Japan.

Teijin Ltd Key Recent Developments

Nov 13,2025: Teijin And BioVaram Form Strategic Alliance To Expand Usage Of Regenerative Medicine Products And Implantable Medical Devices In Japan And India
Nov 11,2025: Teijin Begins Demonstration on Recycled Polycarbonate Resin Traceability
Nov 06,2025: Teijin Pharma Launches YORVIPATH® Treatment for Hypoparathyroidism in Japan
Oct 23,2025: Teijin Pharma Enters Licensing Agreement with Elevara Medicines for Rheumatoid Arthritis Drug

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note:Some sections may be missing if data is unavailable for the company

Table of Contents

65 Pages
Section 1 - About the Company
Teijin Ltd - Key Facts
Teijin Ltd - Key Employees
Teijin Ltd - Key Employee Biographies
Teijin Ltd - Major Products and Services
Teijin Ltd - History
Teijin Ltd - Company Statement
Teijin Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Teijin Ltd - Business Description
Business Segment: Fibers and Products Converting
Overview
Performance
Business Segment: Healthcare
Overview
Performance
Business Segment: Materials
Overview
Performance
Business Segment: Others
Overview
Performance
Geographical Segment: Americas (ex-U.S.)
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe, Others
Performance
Geographical Segment: Japan
Performance
Geographical Segment: PRC
Performance
Geographical Segment: U.S.
Performance
R&D Overview
Teijin Ltd - Corporate Strategy
Teijin Ltd - SWOT Analysis
SWOT Analysis - Overview
Teijin Ltd - Strengths
Teijin Ltd - Weaknesses
Teijin Ltd - Opportunities
Teijin Ltd - Threats
Teijin Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Teijin Ltd, Petrochemicals, Deals By Year, 2019 to YTD 2025
Teijin Ltd, Petrochemicals, Deals By Type, 2019 to YTD 2025
Teijin Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 13, 2025: Teijin And BioVaram Form Strategic Alliance To Expand Usage Of Regenerative Medicine Products And Implantable Medical Devices In Japan And India
Nov 11, 2025: Teijin Begins Demonstration on Recycled Polycarbonate Resin Traceability
Nov 06, 2025: Teijin Pharma Launches YORVIPATH® Treatment for Hypoparathyroidism in Japan
Oct 23, 2025: Teijin Pharma Enters Licensing Agreement with Elevara Medicines for Rheumatoid Arthritis Drug
Oct 23, 2025: Exclusive License Agreement for Rheumatoid Arthritis Treatment Candidate TCK-276 Signed with UK Biotech Company
Oct 01, 2025: Cell Therapies and Teijin Announce Strategic Collaboration to Expand Access to Advanced Cell and Gene Therapies in Japan and the Asia Pacific Region
Sep 09, 2025: Pioneering Sustainability: Teijin Carbon Publishes Its First Sustainability Report
Aug 05, 2025: Teijin Reports Results for Three Months Ended June 30, 2025
Oct 30, 2024: Teijin and Hilleman Laboratories to Expand Business in Asia-Pacific via Strategic Partnership to Promote CDMO Services in Cell and Gene Therapy
Aug 06, 2024: Teijin Announces the Summary of Consolidated Financial Results for the Three Months Ended June 30, 2024
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Teijin Ltd, Key Facts
Teijin Ltd, Key Employees
Teijin Ltd, Key Employee Biographies
Teijin Ltd, Major Products and Services
Teijin Ltd, History
Teijin Ltd, Other Locations
Teijin Ltd, Subsidiaries
Teijin Ltd, Joint Venture
Teijin Ltd, Key Competitors
Teijin Ltd, Ratios based on current share price
Teijin Ltd, Annual Ratios
Teijin Ltd, Annual Ratios (Cont...1)
Teijin Ltd, Annual Ratios (Cont...2)
Teijin Ltd, Interim Ratios
Teijin Ltd, Petrochemicals, Deals By Year, 2019 to YTD 2025
Teijin Ltd, Petrochemicals, Deals By Type, 2019 to YTD 2025
Teijin Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Teijin Ltd, Performance Chart (2021 - 2025)
Teijin Ltd, Ratio Charts
Teijin Ltd, Petrochemicals, Deals By Year, 2019 to YTD 2025
Teijin Ltd, Petrochemicals, Deals by Type, 2019 to YTD 2025

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.